Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$94.59 +0.17 (+0.18%)
As of: Nov 11, 2026 · 11:42 AM EST

Mirum Pharmaceuticals (MIRM) Return on Assets [ROA] (2019 - 2026)

Updated

Mirum Pharmaceuticals' Return on Assets [ROA] was -87.26% in Q3 2026, down 81.78 percentage points from -5.48% a year earlier but up 1.61 percentage points from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Mirum Pharmaceuticals came in at -3.09%, up 10.26 percentage points from FY2024.

  • Return on Assets [ROA] has now increased for three consecutive years, with a five-year change of +50.20 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -13.35% in FY2024 (+19.35 pp), -32.70% in FY2023 (+9.20 pp), -41.90% in FY2022 (-10.53 pp) and -31.37% in FY2021 (+21.92 pp).
  • Quarterly Return on Assets [ROA] has moved between -92.15% (Q1 2026) and -2.87% (Q4 2025) over five years.
  • Compared with a year earlier, Return on Assets [ROA] has declined for three straight quarters, with an average year-over-year change of -23.74 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2022 (a gain of 61.43 percentage points); the worst was Q3 2026 (a drop of 81.78 percentage points).
  • Per Business Quant data, MIRM's Return on Assets [ROA] in the three quarters before Q3 2026 was -88.87% (Q2 2026), -92.15% (Q1 2026) and -2.87% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Mirum Pharmaceuticals 6.16 Bn 4.58 Bn 150.55 Mn -87.26%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -87.26%
Jun 30, 2026 -88.87%
Mar 31, 2026 -92.15%
Dec 31, 2025 -2.87%
Sep 30, 2025 -5.48%
Jun 30, 2025 -8.27%
Mar 31, 2025 -11.37%
Dec 31, 2024 -13.14%
Sep 30, 2024 -15.02%
Jun 30, 2024 -16.63%
Mar 31, 2024 -24.42%
Dec 31, 2023 -25.19%
Sep 30, 2023 -30.01%
Jun 30, 2023 -45.37%
Mar 31, 2023 -37.64%
Dec 31, 2022 -37.83%
Sep 30, 2022 -12.60%
Jun 30, 2022 -18.45%
Mar 31, 2022 -24.46%
Dec 31, 2021 -31.70%
API Access

Mirum Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MIRM&period=max&api_key=YOUR_API_KEY